The G-BA has decided today that the COVID-19 outbreak and the related public restrictions are special circumstances in their internal regulations. Hence they can now also utilize videoconferences and written decision-making. See also details on their website. Their decision is still due until the Ministry of Health decides on the resolution.
So, the market access route for drugs, medical devices, diagnostics, vaccinations is still open and ready for (new) innovations.